https://doi.org/10.4081/monaldi.2018.949
Rhythm-control vs rate-control in the elderly: When to do it and which drug to prefer?
Accepted: May 14, 2018
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Atrial fibrillation (AF) is a relevant cardiovascular condition that is more prevalent in the elderly patients aged over 65 years. AF, with abnormal rate and rhythm can cause symptoms directly or indirectly by exacerbating other frequently coexisting cardiac conditions such as valvular heart disease, hypertension, ischemic cardiomyopathy, dilated cardiomyopathy, and hypertrophic cardiomyopathy. Evidence suggests that aging-related cardiovascular changes predispose to the elderly to AF. Current therapeutic options such as antiarrhythmic drugs have not been extensively evaluated in the elderly population. Emerging pharmacological and non-pharmacological treatment options for the management of AF, such as dronedarone or catheter ablation, are of particular interest in the elderly. The present paper reviews the pathophysiology, diagnosis, and the management of AF in the elderly patient.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Abhishek B J, Agadi Hiremath Viswanatha Swamy, Sanatkumar Bharamu Nyamagoud, Anupama George, Namratha D, Respiratory syncytial virus: an overview of clinical manifestations and management in the Indian pediatric population , Monaldi Archives for Chest Disease: Early Access
- Shyam Kanhaiya Saroj, Tushti Bhardwaj, Non-pharmacological interventions for tobacco cessation: A systematic review of existing practices and their effectiveness , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Danish Abdul Aziz, Muhammad Aqib Sajjad, Ameema Asad, Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Pawan Tiwari, Randeep Guleria, Steroid therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Nicola Troisi, Alfredo Mazza, Felice Mazza, Gabriele Iannelli, Role of matrix metalloproteinase in the aneurismatic aortic disease , Monaldi Archives for Chest Disease: Vol. 62 No. 3 (2004): Cardiac series
- Christophoros Kotoulas, Vasileios Tzilalis, Emmanouil Spyridakis, Ioannis Mamarelis, Endovascular management of a late saccular aortic aneurysm after end-to-end repair of coarctation , Monaldi Archives for Chest Disease: Vol. 76 No. 4 (2011): Cardiac series
- Kostiantyn Dmytriiev, Yuriy Mostovoy, Nataliia Slepchenko, Yuliia Smereka, Clinical course of COPD in patients with Arg16Gly (rs1042713) polymorphism of ADRB2 gene , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Nesrine Lamine, Apostolos C. Agrafiotis, Ines Lardinois, Lipiodol lymphangiography as a treatment for refractory postoperative chylothorax: a case report , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Furio Colivicchi, David Mocini, Massimo Uguccioni, Stefano Strano, Giuseppe Imperoli, Massimo Santini, Smoking cessation interventions after Acute Coronary Syndromes. Results of a cross-sectional survey in the Lazio Region of Italy , Monaldi Archives for Chest Disease: Vol. 78 No. 2 (2012): Cardiac series
- Malay Sarkar, Irappa Madabhavi, Nagaveni Kadakol, Oxygen-induced hypercapnia: physiological mechanisms and clinical implications , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
You may also start an advanced similarity search for this article.
